UK Prostate Cancer Diagnostic and Therapeutic Market to Signify Strong Growth by 2023-2029

UK prostate cancer market is forecast to grow at a CAGR of 9.7% during the forecast period. The high incidence of prostate cancer is the major factor for augmenting the demand for prostate cancer diagnostics services and therapeutics in the country. As per the World Health Organization, around 56,000 new cases of prostate cancer were registered in 2018. It is the most common cancer in the country with around 24% of the overall new cancer cases in men. The 5-year prevalence in the country due to prostate cancer is around 206,000 in 2018.

In UK, prostate cancer is the second largest cause of cancer mortalities with around 13,000 mortalities in 2018. This is primarily due to the increasing aging population of UK. As per Cancer Research UK, more than half (54%) of prostate cancer cases in the UK each year are diagnosed in males aged 70 and over of age. Moreover, incidence rates for prostate cancer are projected to rise by 12% in the UK between 2014 and 2035 and 1 in 8 men will be diagnosed with prostate cancer during their lifetime in the country. Prostate cancer is most common in black males, then White males and least common in Asian males.

To Request a Sample of our Report on UK Prostate Cancer Diagnostic and Therapeutic Market:  https://www.omrglobal.com/request-sample/uk-prostate-cancer-diagnostic-therapeutic-market

UK Prostate Cancer Market Segmentation

By Diagnostic Techniques

  • Prostate-Specific Antigen Test (PSA)
  • Digital Rectal Examination
  • Prostate Biopsy
  • Imaging Techniques

By Therapeutics 

  • Hormonal Therapy
  • Chemotherapy
  • Immunotherapy
  • Radiation Therapy
  • Targeted Therapy
  • Surgery

A full Report of UK Prostate Cancer Diagnostic and Therapeutic Market is Available @  https://www.omrglobal.com/industry-reports/uk-prostate-cancer-diagnostic-therapeutic-market

Company Profiles

  • Abbott Laboratories
  • AbbVie Products, LLC
  • Amgen Inc.
  • AstraZeneca PLC
  • Bayer AG
  • Bristol-Myers Squibb Co.
  • Ferring Pharmaceuticals Inc.
  • GlaxoSmithKline PLC
  • Johnson & Johnson
  • Pfizer Inc.
  • Siemens Healthcare AG
  • MDNA Life SCIENCES, Inc.
  • Ipsen Group

Reasons to buy from us –

  1. We cover more than 15 major industries, further segmented into more than 90 sectors.
  2. More than 120 countries are for analysis.
  3. Over 100+ paid data sources mined for investigation.
  4. Our expert research analysts answer all your questions before and after purchasing your report.

About Orion Market Research 

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

Media Contact:

Company Name: Orion Market Research

Contact Person: Mr. Anurag Tiwari

Email: info@omrglobal.com

Contact no:  +91 7803040404